Press Release

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody,...

Artera: Clinicians and patients throughout New York State can now access personalized, actionable insights to inform prostate cancer treatment decisions SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal...

Proscia: Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges PHILADELPHIA — June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI)...

Elucidata and Sapien Biosciences: This collaboration aims to maximize the value of biobank data through AI-assisted harmonization, leading to precise patient outcomes at scale and lowering the cost of drug discovery. SAN...

PathPresenter: Pre-Congress Workshop, Interoperability Showcase, and Technical Session among PathPresenter's initiatives in Barcelona MONTVILLE, NJ / ACCESS Newswire / June 4, 2025 / PathPresenter, a leading Image Management System and...

Recognition underscores the impact of Proscia in advancing precision medicine from drug discovery to diagnostics PHILADELPHIA — June 3, 2025 — Proscia®, a software company accelerating pathology’s transition to digital and AI, today...